AXYNTIS Group employs nearly 450 people and operates 4 cGMP manufacturing sites in France (2 are also FDA inspected and accredited by PMDA). We provide/offer comprehensive CDMO services to our partners for their API or advanced intermediates projects from early-stage development to commercial phase, including preparative chromatography (KYRAPHARM subsidiary). We also commercialize a range of proprietary API and building blocks. Coming soon in 2022 : high potent API capacity with occupational exposure limits (OEL) down to 1 ng/m³/shift.
Your smart and reliable partner for CDMO services and generic APIs.
Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace
